# Universiteit Antwerpen

Organization · id `cardio:org-universiteit-antwerpen` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ROR record 008x57b05](<https://ror.org/008x57b05>), retrieved 18 November 2026. No person wrote or checked this page.

## In plain language

An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 3 trials in this atlas.

## Technical summary

Sponsor class other. Matched to ROR record 008x57b05 by an exact name.

## The registry's words

- Sponsor name: Universiteit Antwerpen
- Sponsor class: OTHER
- ROR name: University of Antwerp

## Connected pages

- Sponsors: Testing the Value of Novel Strategy and Its Cost Efficacy in Order to Improve the Poor Outcomes in Cardiogenic Shock (`cardio:ct-nct03813134`)
- Sponsors: Metformin as RenoProtector of Progressive Kidney Disease (`cardio:ct-nct03831464`)
- Sponsors: Structured Testing and Treatment for Obstructive Sleep Apnea in Patients With Atrial Fibrillation (`cardio:ct-nct06263608`)

## Provenance

Content hash: a115f3fd65026a12eab483bef867ca9a5acb2367651db91054f5c7c7abee547b
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
